Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | |
|---|---|---|---|---|---|
| Sales | 850.29 | 765.63 | 808.58 | 823.71 | 742.72 |
| Operating profit | 186.31 | 187.15 | 237.87 | 232.85 | 233.02 |
| Interest | 0.63 | 7.18 | 0.70 | 0.07 | 1.17 |
| Gross profit | 221.10 | 208.39 | 265.07 | 285.19 | 262.85 |
| EPS (Rs) | 11.70 | 15.71 | 22.39 | 22.64 | 22.25 |
Quarterly
results in details
| Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | |
|---|---|---|---|---|---|
| Other income | 35.42 | 28.42 | 27.90 | 52.41 | 31.00 |
| Stock adjustment | 32.09 | -45.27 | -22.38 | 34.99 | -23.94 |
| Raw material | 195.05 | 217.01 | 198.61 | 172.99 | 184.43 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 166.92 | 146.11 | 147.90 | 146.93 | 144.93 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 269.92 | 260.63 | 246.58 | 235.95 | 204.28 |
| Provisions made | - | - | - | - | - |
| Depreciation | 30.75 | 30.09 | 30.71 | 30.40 | 29.76 |
| Taxation | 39.98 | 43.46 | 39.65 | 57.94 | 39.63 |
| Net profit / loss | 150.37 | 134.84 | 194.71 | 196.85 | 193.46 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.71 | 17.17 | 17.39 | 17.39 | 17.39 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 21.91 | 24.44 | 29.42 | 28.27 | 31.37 |
| GPM (%) | 24.96 | 26.24 | 31.69 | 32.55 | 33.97 |
| NPM (%) | 16.98 | 16.98 | 23.28 | 22.47 | 25.00 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis